Abstract
In a case-control study, Wammes-van der Heijden et al. investigated whether the intensity of triptan and ergotamine use is associated with the risk of ischemic complications. Triptan overuse did not increase this risk. Overuse of ergotamine proved to be a risk factor, especially in patients with concomitant use of cardiovascular drugs (8.5-fold increase). see page 1128 Commentary by Mark Obermann, MD, and Zaza Katsarava, MD, PhD, MSc Medication overuse headache (MOH) has developed into the third most common type of headache after tension-type headache …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
